2018
DOI: 10.3844/ajisp.2018.26.33
|View full text |Cite
|
Sign up to set email alerts
|

Diabetic Retinopathy: Changes in Levels of Orosomucoids in Patients Supplemented with Beta Glucan and Vitamin D

Abstract: The role of beta glucan in stimulating of various biological reactions is getting more and more attention. In this report, we focused on the effects of oral supplementation with beta glucan and vitamin D on changes in serum levels of orosomucoids in patients with diabetic retinopathy. We measured the level of orosomucoids and evaluated the effects of oral supplementation. In this study we report significant decrease of orosomucoids levels after the end of the three-month treatment. Our results support the fact… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
(90 reference statements)
0
1
0
Order By: Relevance
“…Glucan effects are manifested via binding to several specific receptors, such as CR3 and dectin-1, and subsequent glucan-related signaling pathways include the NFĸB-receptor tyrosine kinase axis (24). Their effects include not only improvements of immune reactions against cancer and infection (7, 25), but also protection against mitochondrial toxicity (26) or improvements in diabetic retinopathy (27). Recently, glucans have been evaluated for their use in vaccine preparation, either as a part of the targeting delivery system or as a nanoparticle-based delivery platform (28).…”
Section: Discussionmentioning
confidence: 99%
“…Glucan effects are manifested via binding to several specific receptors, such as CR3 and dectin-1, and subsequent glucan-related signaling pathways include the NFĸB-receptor tyrosine kinase axis (24). Their effects include not only improvements of immune reactions against cancer and infection (7, 25), but also protection against mitochondrial toxicity (26) or improvements in diabetic retinopathy (27). Recently, glucans have been evaluated for their use in vaccine preparation, either as a part of the targeting delivery system or as a nanoparticle-based delivery platform (28).…”
Section: Discussionmentioning
confidence: 99%